Researchers evaluated feasibility, acceptability, and preliminary efficacy of a patient portal designed for self-management. The researchers also found that the risk of sudden cardiac death was significantly elevated in younger individuals. Investigational parameters included age, time since diabetes diagnosis, BMI, A1c, and lipid profiles. Relationship between the frequency and patterns of vasomotor systems and new cases of diabetes over time Unlike branded medications, compounded products are not required to strictly adhere to FDA's Current Good Manufacturing Patients with inflammatory bowel diseases (IBD) have a moderately increased risk of developing type 1 diabetes (T1D) SGPCRI is calling for nominations for the $1M Stephenson Global Prize and Letters of Intent for their Scholar Grants. A study examined the link between vitamin D levels, GDM prevalence, and neonatal outcomes in pregnant women of color. Vitamin D deficiency emerged as the most prevalent, affecting about 60% of T2D patients studied An analysis of postpartum women ought to inform the development and adaptation of lifestyle programs designed to prevent T2D. may be at risk if their phone settings change following updates to software or hardware Education and financial status also seem to play a role in diabetes diagnosis. consumers bought products containing 27% less sugar, 37% less sodium, and 16% less saturated fat after a similar labeling Drs. Julie Schulz and Michael Dovidio Discuss Using Lab Values for GLP-1 Drug Coverage. Dr. Luke Twelves Talks Clinical Trials Diversity for Type 2 Diabetes Patients Only 11% of patients with type 1 diabetes and 1% of patients with type 2 diabetes received a CGM prescription. Drs. Julia Schulz and Michael Dovidio discuss lab values to determine GLP-1 drug coverage and improve prescription access. Both redlining and lower food access were directly associated with higher prevalence of diabetes, heart disease, and obesity. Dr. Luke Twelves, VP of Medical for Lindus Health discusses the lack of diversity in type 2 diabetes clinical trials. Children who were overweight or obese had a greater risk of a new diabetes diagnosis within 6 months of COVID-19 infection.